The Gold Coast criteria increases the diagnostic sensitivity for amyotrophic lateral sclerosis in a Chinese population
- PMID: 34372918
- PMCID: PMC8351337
- DOI: 10.1186/s40035-021-00253-2
The Gold Coast criteria increases the diagnostic sensitivity for amyotrophic lateral sclerosis in a Chinese population
Abstract
Objectives: The aim of this study was to assess and compare the diagnostic utility of a new diagnostic criteria for amyotrophic lateral sclerosis (ALS), abbreviated as the 'Gold Coast Criteria', with the revised El Escorial (rEEC) and Awaji criteria.
Methods: Clinical and electrophysiological data of 1185 patients from January 2014 to December 2019 in the Peking Union Medical College Hospital ALS database were reviewed. The sensitivity of the Gold Coast criteria was compared to that of the possible rEEC and Awaji criteria (defined by the proportion of patients categorized as definite, probable, or possible ALS).
Results: A final diagnosis of ALS was recorded in 1162 patients. The sensitivity of the Gold Coast criteria (96.6%, 95% confidence interval [CI] = 95.3%-97.5%) was greater than that of the rEEC (85.1%, 95%CI = 82.9%-87.1%) and Awaji (85.3%, 95%CI = 83.2%-87.3%). In addition, the sensitivity of the novel criteria maintained robust across subgroups, and the advantage was more prominent in limb-onset ALS patients and those who completed electromyographic tests. In those who did not achieve any of the rEEC diagnostic categories, the sensitivity of Gold Coast criteria was 84.4%.
Conclusions: The current study demonstrated that the Gold Coast criteria exhibited greater diagnostic sensitivity than the rEEC and Awaji criteria in a Chinese ALS population. The application of the Gold Coast criteria should be considered in clinical practice and future therapeutic trials.
Keywords: Amyotrophic lateral sclerosis; Diagnostic criteria; Gold Coast; Sensitivity.
© 2021. The Author(s).
Conflict of interest statement
None declared.
Figures
Similar articles
-
The Awaji criteria increases the diagnostic sensitivity of the revised El Escorial criteria for amyotrophic lateral sclerosis diagnosis in a Chinese population.PLoS One. 2017 Mar 1;12(3):e0171522. doi: 10.1371/journal.pone.0171522. eCollection 2017. PLoS One. 2017. PMID: 28249004 Free PMC article.
-
Diagnostic Utility of Gold Coast Criteria in Amyotrophic Lateral Sclerosis.Ann Neurol. 2021 May;89(5):979-986. doi: 10.1002/ana.26045. Epub 2021 Feb 24. Ann Neurol. 2021. PMID: 33565111
-
Usefulness of the Gold Coast criteria in diagnosing fast-progressing amyotrophic lateral sclerosis.J Neurol Sci. 2025 Apr 15;471:123418. doi: 10.1016/j.jns.2025.123418. Epub 2025 Feb 10. J Neurol Sci. 2025. PMID: 39987720
-
Awaji criteria improves the diagnostic sensitivity in amyotrophic lateral sclerosis: A systematic review using individual patient data.Clin Neurophysiol. 2016 Jul;127(7):2684-91. doi: 10.1016/j.clinph.2016.04.005. Epub 2016 Apr 16. Clin Neurophysiol. 2016. PMID: 27212114
-
[Awaji criteria: new diagnostic criteria for amyotrophic lateral sclerosis].Rev Neurol (Paris). 2013 Jun-Jul;169(6-7):470-5. doi: 10.1016/j.neurol.2012.10.007. Epub 2012 Dec 20. Rev Neurol (Paris). 2013. PMID: 23261262 Review. French.
Cited by
-
Diagnosing ALS: the Gold Coast criteria and the role of EMG.Pract Neurol. 2022 Jun;22(3):176-178. doi: 10.1136/practneurol-2021-003256. Epub 2022 Jan 6. Pract Neurol. 2022. PMID: 34992096 Free PMC article. No abstract available.
-
Recent advances in the diagnosis and prognosis of amyotrophic lateral sclerosis.Lancet Neurol. 2022 May;21(5):480-493. doi: 10.1016/S1474-4422(21)00465-8. Epub 2022 Mar 22. Lancet Neurol. 2022. PMID: 35334233 Free PMC article. Review.
-
Blood biomarkers in ALS: challenges, applications and novel frontiers.Acta Neurol Scand. 2022 Oct;146(4):375-388. doi: 10.1111/ane.13698. Acta Neurol Scand. 2022. PMID: 36156207 Free PMC article. Review.
-
Iranian clinical practice guideline for amyotrophic lateral sclerosis.Front Neurol. 2023 Jun 2;14:1154579. doi: 10.3389/fneur.2023.1154579. eCollection 2023. Front Neurol. 2023. PMID: 37333000 Free PMC article. Review.
-
Recent developments in consensus diagnostic criteria for amyotrophic lateral sclerosis.eNeurologicalSci. 2025 Feb 1;38:100559. doi: 10.1016/j.ensci.2025.100559. eCollection 2025 Mar. eNeurologicalSci. 2025. PMID: 39981199 Free PMC article. No abstract available.
References
-
- Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2000;1(5):293–9. - PubMed
-
- Traynor BJ, Codd MB, Corr B, Forde C, Frost E, Hardiman OM. Clinical features of amyotrophic lateral sclerosis according to the El Escorial and Airlie house diagnostic criteria: a population-based study. Arch Neurol. 2000;57(8):1171–6. - PubMed
-
- de Carvalho M, Dengler R, Eisen A, England JD, Kaji R, Kimura J, et al. Electrodiagnostic criteria for diagnosis of ALS. Clin Neurophysiol. 2008;119(3):497–503. - PubMed
-
- Douglass CP, Kandler RH, Shaw PJ, McDermott CJ. An evaluation of neurophysiological criteria used in the diagnosis of motor neuron disease. J Neurol Neurosurg Psychiatry. 2010;81(6):646–9. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous